The global increase in life expectancy has intensified the need to understand biological mechanisms underlying healthy ageing. In young adults, nitric oxide (NO) is primarily (~0.74 µmol·kg⁻¹·h⁻¹) produced via the nitric oxide synthase (NOS)-dependent oxidation of L-arginine(1). However, ageing is associated with several physiological changes, including a progressive decline in endogenous NO production and/or bioavailability, driven by reduced NOS expression, activity and coupling; endothelial dysfunction; and increased oxidative stress. An alternative NOS-independent pathway, the nitrate (NO3⁻)–nitrite (NO2⁻)–NO pathway, has been increasingly recognised as an important and complementary means for NO production(2). This pathway is initiated by the reduction of NO3⁻, from endogenous and exogenous (diet) sources, to NO2⁻and the subsequent reduction of NO2⁻ to bioactive NO through processes mediated by oral microbiota, gastric acid and systemic enzymatic reduction (e.g., via xanthine oxidoreductase, deoxyhemoglobin) in peripheral tissues(3). Dietary NO3- may support healthy ageing through the NO3-NO2-NO pathway, yet the translational scope of randomised evidence in middle-aged and older adults remains unclear. This scoping review mapped randomised controlled evidence on dietary NO3- interventions in adults aged ≥ 40 y, focusing on intervention characteristics, study design, participant profiles, mechanistic assessments, and ageing-relevant outcomes. Systematic searches were conducted across MEDLINE, PsycINFO, CINAHL, PubMed, and the Cochrane Library. Eligible studies were randomised controlled trials involving dietary NO3- interventions in adults aged ≥ 40 y. From 10,897 identified records, 127 studies were included, comprising 175 trials and 4,448 participants. The studies were published between 2011 and 2026. Most trials used crossover designs (n = 107; 61.1%), and double-blind protocols predominated (n = 139; 79.4%). Beetroot juice was the dominant NO₃⁻ source tested (n = 116; 66.3%), whereas whole-food sources, typically green leafy vegetables, accounted for fewer than 5% of trials (n = 8; 4.6%). Acute interventions were the most common, with 1-day protocols reported in 69 trials (39.4%), while 42 trials (24.0%) lasted > 1 to ≤ 21 days and 64 trials (36.6%) lasted > 21 days. Most trials administered daily NO₃⁻ doses ≥ 4 mmol (n = 155; 88.6%). Evidence was concentrated around metabolic, cardiorespiratory, and vascular outcomes, particularly blood pressure (n = 128; 73.1%). In contrast, further outcomes central to healthy ageing were underrepresented, including physical function and exercise capacity (n = 23; 13.1%), muscle strength and power (n = 25; 14.3%), brain health (n = 12; 6.9%), and body composition (n = 3; 1.7%). Current evidence on dietary NO3- remains dominated by acute and short-term, supplement-based investigations in adults over 40 years. Few studies have examined long-term interventions, low-dose strategies, whole-food NO₃⁻ sources, cognitive outcomes, body composition or functional endpoints central to healthy ageing. Longer-term, food-based trials assessing accepted ageing-related outcomes are needed to translate dietary NO3- interventions into practical healthy-ageing strategies.